Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies

20 Jan 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to CRISPR and Genetic Engineering
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39833408
DOI: 10.1038/s41591-024-03478-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapiesPMID 39833408Read ↗

Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology PatientsSemantic proximity Read ↗

Replication-Competent Retroviruses in Gene-Modified T Cells Used in Clinical Trials: Is It Time to Revise the Testing Requirements?Semantic proximity Read ↗

Clinical use of lentiviral vectorsSemantic proximity Read ↗

Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generationSemantic proximity Read ↗

Efficient delivery of lentiviral vectors into resting human CD4 T cellsSemantic proximity Read ↗

Lentiviral Vectors for CAR-T and Other Cell Therapy Products: A Microbiological and Biosafety PerspectiveSemantic proximity Read ↗

Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T CellsSemantic proximity Read ↗

Lentiviruses as gene transfer agents for delivery to non-dividing cellsSemantic proximity Read ↗

Lentiviruses in gene therapy clinical researchSemantic proximity Read ↗

Lentivirus for CAR-T and Other Cell Therapy Products: A Microbiological and Biosafety PerspectiveSemantic proximity Read ↗

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndromeSemantic proximity Read ↗

Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell ProductsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.